Cargando…

Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease

Background: Parkinson's disease (PD) is a common neurodegenerative disorder. The contribution of the immune system to its pathogenesis remains incompletely understood. Methods: In this study, we performed comprehensive immune cell profiling in the cerebrospinal fluid (CSF) and peripheral blood...

Descripción completa

Detalles Bibliográficos
Autores principales: Schröder, Jens B., Pawlowski, Matthias, Meyer zu Hörste, Gerd, Gross, Catharina C., Wiendl, Heinz, Meuth, Sven G., Ruck, Tobias, Warnecke, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305582/
https://www.ncbi.nlm.nih.gov/pubmed/30619041
http://dx.doi.org/10.3389/fneur.2018.01081
_version_ 1783382597932417024
author Schröder, Jens B.
Pawlowski, Matthias
Meyer zu Hörste, Gerd
Gross, Catharina C.
Wiendl, Heinz
Meuth, Sven G.
Ruck, Tobias
Warnecke, Tobias
author_facet Schröder, Jens B.
Pawlowski, Matthias
Meyer zu Hörste, Gerd
Gross, Catharina C.
Wiendl, Heinz
Meuth, Sven G.
Ruck, Tobias
Warnecke, Tobias
author_sort Schröder, Jens B.
collection PubMed
description Background: Parkinson's disease (PD) is a common neurodegenerative disorder. The contribution of the immune system to its pathogenesis remains incompletely understood. Methods: In this study, we performed comprehensive immune cell profiling in the cerebrospinal fluid (CSF) and peripheral blood (PB) of PD patients. Ten PD patients were diagnosed according to brain bank criteria and underwent detailed clinical examination, magnetic resonance imaging, PB and CSF immune cell profiling by multiparameter flow cytometry, and cytokine and chemokine measurements by bead-based arrays. Thirteen healthy elderly volunteers served as control population. Results: The proportions of activated T-lymphocytes and non-classical monocytes in the CSF were increased in patients with PD compared to the control group. In accordance, we found increased levels of the pro-inflammatory cytokines IL-2, IL-6 and TNFα and of the monocyte chemoattractant protein 1 (MCP-1) in the CSF of the included PD patients. Conclusions: Our data provide novel evidence for a response of the innate and adaptive immune system in the central nervous system of patients with PD.
format Online
Article
Text
id pubmed-6305582
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63055822019-01-07 Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease Schröder, Jens B. Pawlowski, Matthias Meyer zu Hörste, Gerd Gross, Catharina C. Wiendl, Heinz Meuth, Sven G. Ruck, Tobias Warnecke, Tobias Front Neurol Neurology Background: Parkinson's disease (PD) is a common neurodegenerative disorder. The contribution of the immune system to its pathogenesis remains incompletely understood. Methods: In this study, we performed comprehensive immune cell profiling in the cerebrospinal fluid (CSF) and peripheral blood (PB) of PD patients. Ten PD patients were diagnosed according to brain bank criteria and underwent detailed clinical examination, magnetic resonance imaging, PB and CSF immune cell profiling by multiparameter flow cytometry, and cytokine and chemokine measurements by bead-based arrays. Thirteen healthy elderly volunteers served as control population. Results: The proportions of activated T-lymphocytes and non-classical monocytes in the CSF were increased in patients with PD compared to the control group. In accordance, we found increased levels of the pro-inflammatory cytokines IL-2, IL-6 and TNFα and of the monocyte chemoattractant protein 1 (MCP-1) in the CSF of the included PD patients. Conclusions: Our data provide novel evidence for a response of the innate and adaptive immune system in the central nervous system of patients with PD. Frontiers Media S.A. 2018-12-18 /pmc/articles/PMC6305582/ /pubmed/30619041 http://dx.doi.org/10.3389/fneur.2018.01081 Text en Copyright © 2018 Schröder, Pawlowski, Meyer zu Hörste, Gross, Wiendl, Meuth, Ruck and Warnecke. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Schröder, Jens B.
Pawlowski, Matthias
Meyer zu Hörste, Gerd
Gross, Catharina C.
Wiendl, Heinz
Meuth, Sven G.
Ruck, Tobias
Warnecke, Tobias
Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease
title Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease
title_full Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease
title_fullStr Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease
title_full_unstemmed Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease
title_short Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson's Disease
title_sort immune cell activation in the cerebrospinal fluid of patients with parkinson's disease
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305582/
https://www.ncbi.nlm.nih.gov/pubmed/30619041
http://dx.doi.org/10.3389/fneur.2018.01081
work_keys_str_mv AT schroderjensb immunecellactivationinthecerebrospinalfluidofpatientswithparkinsonsdisease
AT pawlowskimatthias immunecellactivationinthecerebrospinalfluidofpatientswithparkinsonsdisease
AT meyerzuhorstegerd immunecellactivationinthecerebrospinalfluidofpatientswithparkinsonsdisease
AT grosscatharinac immunecellactivationinthecerebrospinalfluidofpatientswithparkinsonsdisease
AT wiendlheinz immunecellactivationinthecerebrospinalfluidofpatientswithparkinsonsdisease
AT meuthsveng immunecellactivationinthecerebrospinalfluidofpatientswithparkinsonsdisease
AT rucktobias immunecellactivationinthecerebrospinalfluidofpatientswithparkinsonsdisease
AT warnecketobias immunecellactivationinthecerebrospinalfluidofpatientswithparkinsonsdisease